glp-1 and liver glp 1 drugs fatty Current Status of Glucagon-like Peptide-1 Receptor Agonists in Metabolic Dysfunction-associated Steatotic Disease: A Clinical Perspective The Era: Why These – Effects of GLP-1 receptor agonists

10.1016/S0140-6736(24)02317-1 [DOI] [PMC free article] [PubMed] 2.Ghusn W, Hurtado MD (2024) Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks

Recently GLP-1 drugs became the weight loss drug for people in mainly western countries to efficiently lose weight without too much hassle

With pervasive stress and the prevalence of nutritionally deficient fast-food options around every corner, losing weight and keeping it off is challenging in today's day and age

Metabolic Features of the Reproductive Phenotypes of Polycystic Ovary Syndrome

For some, it's a way to bypass high costs and limited access, but for doctors and legal experts, it's a troubling trend that raises questions about safety and oversight